Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur T Sands

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|January 4, 2003
The master mammalArthur T Sands
Nature Reviews. Drug Discovery|January 2, 2003
Knockouts model the 100 best-selling drugs--will they model the next 100?Brian P Zambrowicz, Arthur T Sands
Current Opinion in Pharmacology|October 16, 2003
Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industryBrian P Zambrowicz, C Alexander Turner, Arthur T Sands
Trends in Biotechnology|December 18, 2001
Full-speed mammalian genetics: in vivo target validation in the drug discovery processAlejandro Abuin, Kathleen H Holt, Kenneth A Platt, et al.
Oncogene|January 9, 2004
Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growthHeather A Steinman, Hayla K Sluss, Arthur T Sands, et al.
Oncogene|July 20, 2005
Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in developmentHeather A Steinman, Kathleen M Hoover, Marilyn L Keeler, et al.
Bone Research|August 15, 2015
High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypesRobert Brommage, Jeff Liu, Gwenn M Hansen, et al.
Genome Research|September 19, 2008
Large-scale gene trapping in C57BL/6N mouse embryonic stem cellsGwenn M Hansen, Diane C Markesich, Michael B Burnett, et al.
Cancer Research|May 31, 2002
mdmx is a negative regulator of p53 activity in vivoRick A Finch, Dorit B Donoviel, David Potter, et al.
Diabetes Care|June 8, 2015
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 DiabetesArthur T Sands, Brian P Zambrowicz, Julio Rosenstock, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|January 4, 2003
The master mammalArthur T Sands
Nature Reviews. Drug Discovery|January 2, 2003
Knockouts model the 100 best-selling drugs--will they model the next 100?Brian P Zambrowicz, Arthur T Sands
Current Opinion in Pharmacology|October 16, 2003
Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industryBrian P Zambrowicz, C Alexander Turner, Arthur T Sands
Trends in Biotechnology|December 18, 2001
Full-speed mammalian genetics: in vivo target validation in the drug discovery processAlejandro Abuin, Kathleen H Holt, Kenneth A Platt, et al.
Oncogene|January 9, 2004
Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growthHeather A Steinman, Hayla K Sluss, Arthur T Sands, et al.
Oncogene|July 20, 2005
Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in developmentHeather A Steinman, Kathleen M Hoover, Marilyn L Keeler, et al.
Bone Research|August 15, 2015
High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypesRobert Brommage, Jeff Liu, Gwenn M Hansen, et al.
Genome Research|September 19, 2008
Large-scale gene trapping in C57BL/6N mouse embryonic stem cellsGwenn M Hansen, Diane C Markesich, Michael B Burnett, et al.
Cancer Research|May 31, 2002
mdmx is a negative regulator of p53 activity in vivoRick A Finch, Dorit B Donoviel, David Potter, et al.
Diabetes Care|June 8, 2015
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 DiabetesArthur T Sands, Brian P Zambrowicz, Julio Rosenstock, et al.
Pageof 2